Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Nowak

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
European Journal of Heart Failure|March 31, 2021
Decongestion discriminates risk for one-year mortality in patients with improving renal function in acute heart failureNicholas Wettersten, Yu Horiuchi, Dirk J van Veldhuisen, et al.
European Journal of Heart Failure|December 6, 2011
Influence of age, race, sex, and body mass index on interpretation of midregional pro atrial natriuretic peptide for the diagnosis of acute heart failure: results from the BACH multinational studyLori B Daniels, Paul Clopton, Mihael Potocki, et al.
Emergency Medicine Journal : EMJ|September 11, 2012
Mid-regional pro-adrenomedullin improves disposition strategies for patients with acute dyspnoea: results from the BACH trialMartin Möckel, Julia Searle, Oliver Hartmann, et al.
Journal of the American College of Cardiology|May 8, 2010
Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trialAlan Maisel, Christian Mueller, Richard Nowak, et al.
Circulation. Heart Failure|July 19, 2011
Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) studyAlan Maisel, Yang Xue, Kevin Shah, et al.
Muscle & Nerve|December 22, 2018
Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravisKatherine M Clifford, Lisa D Hobson-Webb, Michael Benatar, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
European Journal of Heart Failure|March 31, 2021
Decongestion discriminates risk for one-year mortality in patients with improving renal function in acute heart failureNicholas Wettersten, Yu Horiuchi, Dirk J van Veldhuisen, et al.
European Journal of Heart Failure|December 6, 2011
Influence of age, race, sex, and body mass index on interpretation of midregional pro atrial natriuretic peptide for the diagnosis of acute heart failure: results from the BACH multinational studyLori B Daniels, Paul Clopton, Mihael Potocki, et al.
Emergency Medicine Journal : EMJ|September 11, 2012
Mid-regional pro-adrenomedullin improves disposition strategies for patients with acute dyspnoea: results from the BACH trialMartin Möckel, Julia Searle, Oliver Hartmann, et al.
Journal of the American College of Cardiology|May 8, 2010
Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trialAlan Maisel, Christian Mueller, Richard Nowak, et al.
Circulation. Heart Failure|July 19, 2011
Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) studyAlan Maisel, Yang Xue, Kevin Shah, et al.
Muscle & Nerve|December 22, 2018
Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravisKatherine M Clifford, Lisa D Hobson-Webb, Michael Benatar, et al.
Pageof 9